Unibest
← Back to patent-cliff list

CAS 1802149-87-6

5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one

Codes: AZD-7986-020

Application context (from source-drug indications)

BronchiectasisBrensocatibLung diseaseBrensocatibSinusitisBrensocatibCystic fibrosisBrensocatibHepatic function declineBrensocatibRenal impairmentBrensocatib

Source drugs (routes using this intermediate)

DrugTierExpiry
BrensocatibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methyl-1,3-benzoxazol-2(3H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.